The FDA approved Zanvastro, the first disease-modifying treatment for Alexander disease, a potentially fatal neurological disorder affecting fewer than one in a million people. Developed with Ionis Pharmaceuticals after over 30 years of research, it stabilized motor function in trials and improved m